Allergy Alert: FDA Issues Recall for Frozen Olive Flounder Sashimi Over Undeclared Allergens

The U.S. Food and Drug Administration (FDA) issued a recall on July 1, 2026, for specific batches of frozen olive flounder sashimi due to undeclared wheat, soy, and sesame, according to an official press release. The products, manufactured by EUNHA, pose a severe risk to individuals with allergies to these ingredients.

Details of the Recall

The affected products include frozen olive flounder sashimi with lot numbers 20260615 and 20260620, sold under the brand name EUNHA. The FDA identified the allergens during routine testing, as reported in a July 1, 2026, statement. The recall applies to packages with expiration dates through December 2026.

“Consumers with allergies to wheat, soy, or sesame should avoid these products immediately,” the FDA warned. The agency emphasized that the allergens were not listed on the packaging, violating federal labeling regulations.

Risks and Symptoms

Exposure to undeclared allergens can trigger severe reactions, including anaphylaxis, according to the American College of Allergy, Asthma, and Immunology (ACAAI). Symptoms may include hives, swelling, difficulty breathing, and, in extreme cases, death. The ACAAI advises individuals with known allergies to check product labels carefully and contact manufacturers if unsure.

Consumer Actions

Consumers who purchased the affected products are urged to discard them or return them to the place of purchase for a refund. EUNHA’s customer service hotline is available at 1-800-555-1234, as stated in the FDA’s recall notice. The FDA also recommends that consumers contact their healthcare providers if they experience allergic reactions after consuming the product.

Food Safety Implications

This recall highlights ongoing challenges in food safety, particularly with imported seafood. The FDA’s 2025 report on allergen management in processed foods noted that 12% of food recalls in the U.S. involved undeclared allergens. The agency has since increased inspections of foreign facilities, including those in South Korea, where EUNHA is based.

Industry Response

EUNHA issued a statement on July 1, 2026, expressing regret for the oversight and confirming cooperation with the FDA. “We are conducting a full investigation to prevent future incidents,” the company said. The FDA’s ongoing investigation aims to determine how the allergens were introduced during processing.

What to Do If You Have Allergies

Individuals with food allergies should always read labels carefully and inquire about manufacturing practices. The FDA’s Food Safety Modernization Act (FSMA) requires companies to implement allergen control plans, but enforcement remains a focus for regulators. Consumers can report issues via the FDA’s Safety Reporting Portal.